pubmed-article:17052808 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17052808 | lifeskim:mentions | umls-concept:C0948265 | lld:lifeskim |
pubmed-article:17052808 | lifeskim:mentions | umls-concept:C0166418 | lld:lifeskim |
pubmed-article:17052808 | lifeskim:mentions | umls-concept:C1442959 | lld:lifeskim |
pubmed-article:17052808 | lifeskim:mentions | umls-concept:C1521991 | lld:lifeskim |
pubmed-article:17052808 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:17052808 | pubmed:dateCreated | 2006-11-22 | lld:pubmed |
pubmed-article:17052808 | pubmed:abstractText | Over recent years, obesity rates and the onset of obesity-induced chronic diseases have risen dramatically. The more we learn about the physiological and morphological changes that occur during obesity, the more it is becoming clear that obesity-related disorders can be traced back to adipocyte hypertrophy and inflammation at white adipose tissue (WAT). To combat this problem, the body has developed a regulatory system specifically designed at mediating the systemic response to obesity, utilizing free fatty acids (FFAs) and their metabolites as nutrient messengers to signal adaptations from peripheral tissues. These messages are predominantly interceded through the peroxisome proliferator-activated receptors (PPARs), a family of ligand-induced transcription factors that serve as a net of lipid sensors throughout the body. Understanding how and why nutrients, nutrient derivatives and metabolites exert their physiological effects are the key goals in the study of molecular nutrition. By learning about the mechanisms and tissue-specific effects of endogenous PPAR ligands and expanding our knowledge of the body's integrated homeostatic system, we will significantly increase our odds of designing safe and effective preventive and therapeutic interventions that keep us one step ahead of obesity-related diseases. | lld:pubmed |
pubmed-article:17052808 | pubmed:language | eng | lld:pubmed |
pubmed-article:17052808 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17052808 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17052808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17052808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17052808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17052808 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17052808 | pubmed:month | Dec | lld:pubmed |
pubmed-article:17052808 | pubmed:issn | 0261-5614 | lld:pubmed |
pubmed-article:17052808 | pubmed:author | pubmed-author:HontecillasRa... | lld:pubmed |
pubmed-article:17052808 | pubmed:author | pubmed-author:Bassaganya-Ri... | lld:pubmed |
pubmed-article:17052808 | pubmed:author | pubmed-author:GuriAmir JAJ | lld:pubmed |
pubmed-article:17052808 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17052808 | pubmed:volume | 25 | lld:pubmed |
pubmed-article:17052808 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17052808 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17052808 | pubmed:pagination | 871-85 | lld:pubmed |
pubmed-article:17052808 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:17052808 | pubmed:meshHeading | pubmed-meshheading:17052808... | lld:pubmed |
pubmed-article:17052808 | pubmed:meshHeading | pubmed-meshheading:17052808... | lld:pubmed |
pubmed-article:17052808 | pubmed:meshHeading | pubmed-meshheading:17052808... | lld:pubmed |
pubmed-article:17052808 | pubmed:meshHeading | pubmed-meshheading:17052808... | lld:pubmed |
pubmed-article:17052808 | pubmed:meshHeading | pubmed-meshheading:17052808... | lld:pubmed |
pubmed-article:17052808 | pubmed:meshHeading | pubmed-meshheading:17052808... | lld:pubmed |
pubmed-article:17052808 | pubmed:meshHeading | pubmed-meshheading:17052808... | lld:pubmed |
pubmed-article:17052808 | pubmed:meshHeading | pubmed-meshheading:17052808... | lld:pubmed |
pubmed-article:17052808 | pubmed:meshHeading | pubmed-meshheading:17052808... | lld:pubmed |
pubmed-article:17052808 | pubmed:meshHeading | pubmed-meshheading:17052808... | lld:pubmed |
pubmed-article:17052808 | pubmed:meshHeading | pubmed-meshheading:17052808... | lld:pubmed |
pubmed-article:17052808 | pubmed:meshHeading | pubmed-meshheading:17052808... | lld:pubmed |
pubmed-article:17052808 | pubmed:meshHeading | pubmed-meshheading:17052808... | lld:pubmed |
pubmed-article:17052808 | pubmed:meshHeading | pubmed-meshheading:17052808... | lld:pubmed |
pubmed-article:17052808 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:17052808 | pubmed:articleTitle | Peroxisome proliferator-activated receptors: bridging metabolic syndrome with molecular nutrition. | lld:pubmed |
pubmed-article:17052808 | pubmed:affiliation | Laboratory of Nutritional Immunology and Molecular Nutrition, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA. | lld:pubmed |
pubmed-article:17052808 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17052808 | pubmed:publicationType | Review | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17052808 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17052808 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17052808 | lld:pubmed |